Anti-PD-L1 for metastatic triple-negative breast cancer.

Anti-PD-L1 for metastatic triple-negative breast cancer.

Item
http://www.wikidata.org/entity/Q53520708
Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyondPrecision medicine in breast cancer: reality or utopia?New Immunotherapy Strategies in Breast Cancer.Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer.PD-L1 Expression Is Associated with Tumor FOXP3(+) Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient.An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.Basis for molecular diagnostics and immunotherapy for esophageal cancer.The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45).Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers.Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis.Risk Factors and Preventions of Breast Cancer.Triple negative breast cancer - prognostic role of immune-related factors: a systematic review.Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments.Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma
P2860

Anti-PD-L1 for metastatic triple-negative breast cancer.

Item
http://www.wikidata.org/entity/Q53520708
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Anti-PD-L1 for metastatic triple-negative breast cancer.
@en
Anti-PD-L1 for metastatic triple-negative breast cancer.
@nl
type
label
Anti-PD-L1 for metastatic triple-negative breast cancer.
@en
Anti-PD-L1 for metastatic triple-negative breast cancer.
@nl
prefLabel
Anti-PD-L1 for metastatic triple-negative breast cancer.
@en
Anti-PD-L1 for metastatic triple-negative breast cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Anti-PD-L1 for metastatic triple-negative breast cancer.
@en
P2093
P304
P31
P356
10.1016/S1470-2045(15)70208-1
P433
P478
P577
P698